FOXL2 Knockdown Inhibits the Progression of Endometriosis
American Journal of Reproductive Immunology · 2025
DOI: 10.1111/aji.70043 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Bing Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Endometriosis, Forkhead Box Protein L2, Endometrium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Scientific Research Project of Wuxi Commission of Health and Family Planning, Wuxi Medical Development Discipline, Elite Talent Project of Wuxi Maternity and Child Care Healthy Hospital of Jiangnan University.
Abstract (Originalsprache)
Problem Endometriosis (EM) is known as a common estrogen‐dependent chronic inflammatory disease. Elevated levels of Forkhead box L2 (FOXL2) have been observed in uterine diseases, including EM. However, the molecular mechanism of FOXL2 in EM needs to be further illustrated. This study aimed to investigate the regulatory role of FOXL2 in EM rats and isolated ectopic endometrial stromal cells (EC‐ESCs). Method of Study FOXL2 knockdown were designed to evaluate the effects of FOXL2 in EM model rats and EC‐ESCs. Hematoxylin‐eosin (HE) staining was used to evaluate the pathological morphology of ectopic endometrium. Reverse transcriptase quantitative polymerase chain reaction (RT‐qPCR) analysis and immunohistochemistry (IHC) were applied to detect the expression of FOXL2, EM‐related genes, and epithelial to mesenchymal transition‐related proteins. The proliferation, migration, invasion, and apoptosis of EC‐ESCs were determined by 5‐ethynyl‐2′‐deoxyuridine (EDU) assay, Transwell assay, and flow cytometry.
Results
The FOXL2 level was remarkably higher in the ectopic endometrial tissue than that in the normal endometrial tissue. Knockdown of FOXL2 notably improved the pathological morphology of EM in rats, and decreased expression levels of ER‐α, ER‐ß, and Cyp19a. Additionally, down‐regulation of FOXL2 suppressed cells proliferation, migration and invasion, and stimulated more apoptotic cells in EC‐ESCs. Besides, FOXL2‐small interfering RNA (FOXL2‐siRNA) treatment resulted in enhanced cleaved‐Caspase3 protein expression and cleaved‐Caspase3/Caspase3 ratio in EC‐ESCs.
Conclusion
FOXL2 participates in the occurrence and development of EM through promoting epithelial‐mesenchymal transition procession and enhancing the migration and invasion of EC‐ESCs, suggesting that FOXL2 may be a new therapeutic target for the EM therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
- Department of Obstetrics and Gynecology, Wuxi Maternity and Child Health Care Hospital, Affiliated Women's Hospital of Jiangnan University, Wuxi, Jiangsu, China.
ORCID-Profile: Bing Zhang
Förderung
- Scientific Research Project of Wuxi Commission of Health and Family Planning
- Wuxi Medical Development Discipline
- Elite Talent Project of Wuxi Maternity and Child Care Healthy Hospital of Jiangnan University
Zitieren
APA
Zhang, B., Li, S. J., Yuan, H., Cong, S. S., Zhao, S. J., & Yang, X. J. (2025). FOXL2 Knockdown Inhibits the Progression of Endometriosis. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70043
Vancouver
Zhang B, Li SJ, Yuan H, Cong SS, Zhao SJ, Yang XJ. FOXL2 Knockdown Inhibits the Progression of Endometriosis. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70043
BibTeX
@article{Zhang2025,
author = {Zhang, Bing and Li, Shang-Jin and Yuan, Hua and Cong, Shan-Shan and Zhao, Shao-Jie and Yang, Xiao-Jun},
title = {FOXL2 Knockdown Inhibits the Progression of Endometriosis},
journal = {American Journal of Reproductive Immunology},
year = {2025},
doi = {10.1111/aji.70043}
}
EUVIMED